整个肺部的SARS-CoV2感染主要针对显示子集特定反应的巨细胞
Thien-Phong Vu Manh1, Carla Gouin2, Julien De Wolf2,3
1Aix-Marseille University, CNRS, INSERM, CIML, Centre d'Immunologie de Marseille-Luminy, Turing Center for Living Systems, 13009, Marseille, France. thien-phong.vu-manh@cnrs.fr.
膜和单细胞衍生的巨细胞是SARS-CoV-2进入人类肺部的主要目标. 它们的炎症反应会影响COVID-19的严重程度,这表明治疗点.
科学领域:
- 传染性疾病 传染性疾病
- 免疫学 免疫学 免疫学
- 呼吸系统医学 呼吸系统医学
背景情况:
- 了解早期的SARS-CoV-2感染对于COVID-19结果至关重要.
- 现有的动物和体外模型在复制人类呼吸系统复杂性方面存在局限性.
研究的目的:
- 为SARS-CoV-2感染研究开发和利用一种创新的ex vivo人类肺部模型.
- 在人类肺部内识别SARS-CoV-2的初始细胞点.
- 描述肺巨子子集对SARS-CoV-2的差异反应.
主要方法:
- 使用肺移植技术开发出一种全人肺部感染的ex vivo模型.
- 单细胞RNA测序 (scRNA-seq) 用于分析细胞反应.
- 孤立的肺免疫细胞子集 (巨细胞,单细胞) 对SARS-CoV-2变体的暴露.
主要成果:
- 气膜巨细胞 (AMs) 和单细胞衍生巨细胞 (MoMacs) 被确定为SARS-CoV-2进入的主要初始标.
- 与AMs相比,MoMacs表现出较高的炎症性细胞因子产生.
- 非经典单细胞 (ncMos) 对炎症反应的贡献最小.
- 武汉SARS-CoV-2的血统在剂量依赖的程度上比D614G变种更强大.
结论:
- 肺部巨细胞,特别是AMs和MoMacs,是SARS-CoV-2的主要入口点.
- 这些巨细胞的炎症反应可以影响随后的组织损伤.
- 针对病毒-巨细胞相互作用可能是COVID-19的可行的预防策略.
更多相关视频
06:29Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo
Published on: May 5, 2023
09:57Flow Cytometric Analysis for Identification of the Innate and Adaptive Immune Cells of Murine Lung
Published on: November 16, 2021
相关概念视频
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Cell-mediated Immune Responses
